Smith & Nephew
Corporate

Select your country

Smith & Nephew

Advanced Search
  • Home
  • About Us
  • Innovation & Products
  • Sustainability
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • News & Media
  • Archived News
  • Smith & Nephew appoints Roger Teasdale as Advanced Wound Management President
  • Home >
  • News & Media >
  • Archived News >
  • Smith & Nephew appoints Roger Teasdale as Advanced Wound Management President
  • Contact
  • Print
  • Forward

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

    Visitor verfication

Email sent successfully
Error: Check all fields are valid. Exclude special characters from Comments field
Smith
Nephew

Smith & Nephew appoints Roger Teasdale as Advanced Wound Management President

30 April 2009

Smith & Nephew plc (NYSE:SNN; LSE: SN) announces today the appointment of Roger Teasdale as President of its Advanced Wound Management business.

Mr. Teasdale, 42, has been with Smith & Nephew for 20 years and has experience in driving top line growth and expanding margins.  He has excellent experience in sales, marketing and executive leadership.  Most recently he served as Senior Vice President Advanced Woundcare and was also, at the same time, Interim President North America for a year.

Dave Illingworth, Chief Executive Officer of Smith & Nephew, commenting on this appointment said, “Smith & Nephew is fortunate to have in Roger an excellent leader who can lead our Advanced Wound Management Division.  With his long experience in the advanced woundcare market and his recent experience in the US Roger will be able to continue the development of the business and the pursuit of its strategy; to expand the business in the US, improve margins and build a significant market share in the Negative Pressure Wound Therapy market.  Roger will be instrumental in helping us build an even stronger leadership position in the advanced woundcare marketplace.  I look forward to his contributions.”

Mr. Teasdale will start his new position on 1 May 2009 and will be based at the Advanced Wound Management Division headquarters in Hull as well as spending a substantial portion of his time at the US Advanced Wound Management headquarters in St Petersburg Florida.

Mr Teasdale is replacing Joe Woody who is leaving the Company after 3 years as President of the Advanced Woundcare division to pursue other business opportunities in the US.  Dave Illingworth, Chief Executive Officer of Smith & Nephew, commenting said, “Mr Woody has made an outstanding contribution to Smith & Nephew both in Advanced Wound Management and in his previous role in Orthopaedics.  He leaves Advanced Wound Management with a strong platform for future growth”.

Mr. Teasdale received his BA (Hons) degree in Accounting and Management Control from Sheffield University.  He currently resides in northern England with his wife and two children.

Enquiries

Investors  
Liz Hewitt Tel: +44 (0) 20 7401 7646
Smith & Nephew   
Group Director Corporate Affairs  
  
Media  
Jon Coles Tel: +44 (0) 20 7404 5959
Brunswick – London  
  
Cindy Leggett-Flynn  Tel:  +1 (212) 333 3810
Brunswick – New York  

About us

Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management.  Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives.  The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.  The Company operates in 32 countries around the world.  Annual sales in 2008 were nearly $3.8 billion.

  • ◊ Trademark of Smith & Nephew
  • Accessibility
  • Terms of Use
  • Copyright & Disclaimer